Evidence map›Paper›PMID 35628212›Full record

ArticleInternational journal of molecular sciences2022

Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of

Shakeel Ahmad Khan, Terence Kin Wah Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Polyporusterone E, a Key Component ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Annals of medicine · 2024
    Article
  9. Article
  10. Vasorelaxant and Blood Pressure-Lowering Effects ofInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shakeel Ahmad KhanDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Rd., Hung Hom, Kowloon 999077, Hong Kong.
Terence Kin Wah LeeDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Rd., Hung Hom, Kowloon 999077, Hong Kong.ORCID 0000-0003-0682-322X
Hong Kong Polytechnic University · HK

Funding

National Natural Science Foundation of China 81871935
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a malignancy with a high mortality rate globally. For thousands of years,

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsCnidiumErbB ReceptorsHumansMolecular Docking SimulationPhosphatidylinositol 3-KinasesPhytochemicalsErbB ReceptorsPhosphatidylinositol 3-KinasesPhytochemicalsactive phytochemicalsCnidium monnierihepatocellular carcinomamolecular mechanismnetwork pharmacology

Identifiers

PMID35628212
PMCPMC9140548
OpenAlexW4280555373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.